ICUI up +14.54% percent right now. $ICUI High is a
Post# of 102233
Recent News posted below.
ICUI Icu Medical Recent Headline News
Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 32 mins ago
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), EGRX: 13.50 (unch)
Upgrade Alert for ICU Medical (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 6:59AM CST
ICU Medical (NASDAQ:ICUI) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $71.81 on volume of 194,000 shares, above average daily volume of 126,000. ICU Medical share prices have moved between a 52-week high of $85.00 and a 52-week low of $35.58 and closed yesterday at 102% above that low price at $71.81 per share. The 200-day and 50-day moving averages have moved 0.16% higher and 0.83% higher over the past week, respectively.
ICUI: 82.16 (+10.35)
ICU Medical posts 3Q profit
Automated Insights - Tue Nov 11, 4:11AM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Tuesday reported profit of $6.4 million in its third quarter.
ICUI: 82.16 (+10.35)
ICU Medical's (ICUI) CEO Vivek Jain on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 6:51PM CST
ICUI: 82.16 (+10.35)
ICU Medical beats by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:32PM CST
ICUI: 82.16 (+10.35)
ICU Medical (ICUI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
ICUI: 82.16 (+10.35)
ICU Medical, Inc. Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical", a leader in innovative medical devices used in vascular therapy, oncology and critical care applications, today announced financial results for the third quarter and nine months ended September 30, 2014.
ICUI: 82.16 (+10.35)
Walgreens Hits the Rock with Court's Ruling on CFO Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:30PM CST
The controversy surrounding an inflated fiscal 2016 earnings forecast continues for leading drugstore chain Walgreen Co. (WAG).
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), WAG: 67.61 (-0.17)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST
HK: 2.89 (-0.36), WWD: 48.11 (-3.70), LLNW: 2.66 (+0.16), FXEN: 2.71 (-0.14), RMTI: 11.17 (+0.27), CZR: 11.18 (-0.36), EGY: 6.82 (-0.17), ICUI: 82.16 (+10.35), ICEL: 7.53 (-0.17), SAAS: 9.16 (+0.19), DMD: 5.73 (-1.40), NPSP: 29.26 (+2.35), SCLN: 8.14 (+0.04), ATHX: 1.51 (-0.03), CMLS: 3.11 (-0.18), TC: 2.16 (+0.20), ATW: 36.28 (-1.48), CLUB: 6.07 (-0.70), RAX: 42.25 (+4.93), PTLA: 27.50 (-0.15), IPAR: 29.08 (-0.14), ATLS: 37.00 (+0.13), AMBC: 24.38 (+1.01), CUI: 8.50 (+0.08), PDLI: 8.10 (+0.17), OMER: 18.58 (+1.09), PRAA: 61.69 (-2.16), CARA: 8.55 (-0.20), HALO: 8.83 (-0.49), MODN: 10.63 (+0.53), CALL: 8.68 (-1.81), ASEI: 48.50 (-7.59), HGR: 20.88 (+0.29), ERII: 4.41 (-0.57)
BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), BIOS: 5.70 (+0.11)
Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), OMCL: 31.93 (-0.56)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), HSP: 56.72 (+0.74)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), SPHS: 2.70 (-0.05)
Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), RMTI: 11.17 (+0.27)
CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), CVS: 89.90 (+0.71)
Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), HAE: 36.89 (+0.23)
14.1% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 04, 11:13AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 14.13% as of today's recent price of $70.99.
ICUI: 82.16 (+10.35)
Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 82.16 (+10.35), CSII: 29.85 (-0.17), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60)
Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), ATRC: 17.76 (+0.07)